COMMUNIQUÉS West-GlobeNewswire

HealthEquity Announces Third Quarter Earnings Release Date
30/10/2024
DRAPER, Utah, Oct. 30, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation’s largest health savings account (“HSA") custodian, today announced plans to release its [...]
Standard BioTools Reports Third Quarter 2024 Financial Results
30/10/2024
SOUTH SAN FRANCISCO, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company”) today announced unaudited interim financial results for the third quarter ended September 30, 2024. [...]
Day One Reports Third Quarter 2024 Financial Results and Corporate Progress
30/10/2024
Achieved $20.1 million in OJEMDA TM (tovorafenib) net product revenue Ended the third quarter with $558.4 million in cash, cash equivalents and short-term investments Company to host conference call and webcast today, [...]
MIMEDX Announces Third Quarter 2024 Operating and Financial Results
30/10/2024
Net Sales of $84 million Grew 3% Year-Over-Year for the Third Quarter Third Quarter GAAP Net Income and Earnings Per Share were $8 Million and $0.05 , Respectively Third Quarter Adjusted EBITDA was $18 Million, or 22% [...]
Biomea Fusion Presents Preclinical Data Showing Icovamenib (BMF-219) Enhanced Effectiveness of GLP-1-Based Therapies and Introduces BMF-650, a Next-Generation, Oral Small-Molecule GLP-1 Receptor Agonist Candidate
30/10/2024
Preclinical data from ex vivo human islet experiments showed that icovamenib (BMF-219) was able to enhance the activity of glucagon-like peptide-1 (GLP-1)-based therapies, potentially leading to increased insulin [...]
Inventiva announces the positive recommendation of the fifth DMC of the NATiV3 Phase 3 clinical trial with lanifibranor in patients with MASH
30/10/2024
The Data Monitoring Committee recommended to continue the clinical trial without modification of the current protocol, based on the pre-planned review of safety data. The recommendation was based on the unblinded review [...]
Inventiva annonce la recommandation positive du cinquième DMC de l’étude clinique NATiV3 Phase 3 avec lanifibranor dans la MASH
30/10/2024
Le Data Monitoring Committee recommande sur la base d’une revue planifiée des données de sécurité que l’étude clinique de Phase III continue sans modification du protocole actuel. L’évaluation était basée sur l’examen [...]
PAT : Résultats semestriels 2024 non consolidés
30/10/2024
Vandœuvre-lès-Nancy, le 30 octobre 2024 - 18 : 00 (CET) Communiqué de presse Pour diffusion immédiate Résultats semestriels 2024 de PAT non consolidés Résultats au 30 juin 2024 bénéficiaires Chiffre d’affaires PAT : 1, [...]
Monopar Therapeutics Inc. Announces Closing of $19.2 Million Public Offering of Common Stock
30/10/2024
WILMETTE, Ill., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) (“Monopar Therapeutics” or the “Company”) , a clinical-stage biotechnology company focused on developing innovative treatments [...]
Cannabis Means Business — a Bold New Vision for CWCBExpo
30/10/2024
The Leading New York Cannabis Trade Show & Conferences Launches an Exciting New Vision and Rebrand Reflecting the New Directions for Advancing the Vast Cannabis Industry NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) -- [...]
Enlitic, Inc. Joins ‘Radiology Reimagined’ Demonstration at RSNA 2024
30/10/2024
Collaborative effort highlights integration of AI into radiology workflow FORT COLLINS, Colo., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Enlitic announced today that it will take part in “ Radiology Reimagined: AI, innovation [...]
Castle Connolly Private Health Partners, LLC Would Like to Recognize Sandra Gilban, MD and Peggy Elango, DO for Being Named as One of the Top 9 Concierge Doctors in New York City
30/10/2024
NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) -- On October 14th, 2024 Gotham Magazine named two of our partner physicians as The 9 Best Concierge Doctors in NYC. Gotham Magazine is a New York City-based magazine that covers [...]
Houston Zoo Partners with BlueSprig to Enhance Inclusivity for Families with Autism
30/10/2024
The partnership brings sensory-friendly attractions to the zoo’s events, including Zoo Boo and Zoo Lights HOUSTON, Oct. 30, 2024 (GLOBE NEWSWIRE) -- In a groundbreaking initiative aimed at fostering inclusivity, the [...]
Elixir Medical’s LithiX HC-IVL System Data Demonstrate Sustained Safety and Efficacy at Six Months
30/10/2024
Elixir Medical’s LithiX HC-IVL System Data Demonstrate Sustained Safety and Efficacy at Six Months —Data from Elixir’s PINNACLE I trial for calcium fragmentation in calcified coronary artery lesions presented at TCT— — [...]
Les données du système LithiX HC – IVL d’Elixir Medical démontrent une sécurité et une efficacité prolongées après six mois
30/10/2024
Les données du système LithiX HC – IVL d’Elixir Medical démontrent une sécurité et une efficacité prolongées après six mois —Données des essais cliniques PINNACLE I d’Elixir dans la fragmentation des calcifications [...]
Comprehensive Healthcare launches “What we do means more” recruitment campaign highlighting rewarding careers in community behavioral health
30/10/2024
YAKIMA, Wash., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Access to quality community behavioral healthcare is life-changing for adults, families and youth facing mental health challenges. Being a part of the team that delivers [...]
Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock
28/10/2024
BRISBANE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (“Vera”), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with [...]
EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock
28/10/2024
WATERTOWN, Mass., Oct. 28, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with [...]
NewAmsterdam Pharma to Participate in Upcoming Medical and Investor Conferences in November
28/10/2024
NAARDEN, The Netherlands and MIAMI, Oct. 28, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral [...]

Pages